No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies
- 2 December 2008
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 48 (3), 239-249
- https://doi.org/10.1002/gcc.20634
Abstract
The etiology of Langerhans cell histiocytosis (LCH), a disease characterized by uncontrolled proliferation of Langerhans cells, is unknown. Although some believe that LCH is reactive, others support a neoplastic origin. We tested the hypothesis that LCH is neoplastic by investigating potential consistent chromosomal aberrations in LCH cells. We used multiparameter DNA flow cytometry to analyze the DNA ploidy LCH cells in 20 cases, performed karyotype analysis in 31 cases, array‐based comparative genomic hybridization (arrayCGH) and single nucleotide polymorphism (SNP) arrays with DNA from flow‐sorted CD1a‐positive and CD1a‐negative cells in 19 cases. Ploidy analysis revealed diploid DNA content in all cases. The karyotype of all patients analyzed was normal, excluding the presence of balanced translocations. ArrayCGH and SNP arrays did not show genome abnormalities. Despite positive TP53 protein immunohistochemical staining, sequencing of exon 5 to 8 of p53 gene showed no alterations in 7 cases. This study strongly suggests that gross chromosomal abnormalities do not cause LCH. Although we cannot exclude cryptic point mutations in as yet unidentified genes, this study of 72 LCH cases shows that LCH may be the result of restricted oligoclonal stimulation rather than unlimited neoplastic proliferation.Keywords
This publication has 28 references indexed in Scilit:
- Optimized amplification and fluorescent labeling of small cell samples for genomic array‐CGHCytometry Part A, 2007
- Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the diseaseThe Journal of Pathology, 2007
- Analysis of Loss of Heterozygosity in Single-System and Multisystem Langerhans' Cell HistiocytosisPediatric and Developmental Pathology, 2007
- Quantification of Homozygosity in Consanguineous Individuals with Autosomal Recessive DiseaseAmerican Journal of Human Genetics, 2006
- p53 Mutation Analysis in Breast Tumors by a DNA Microarray MethodCancer Epidemiology, Biomarkers & Prevention, 2006
- High‐resolution multi‐parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin‐embedded tissuesThe Journal of Pathology, 2005
- Insights from genomic microarrays into structural chromosome rearrangementsAmerican Journal of Medical Genetics Part A, 2004
- An Hypothesis Langerhans cell histiocytosis: The failure of the immune system to switch from an innate to an adaptive modePediatric Blood & Cancer, 2003
- Treatment of Multisystem Langerhans Cell Histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 StudiesKlinische Padiatrie, 2000
- Langerhans cell histiocytosisThe Journal of Pediatrics, 1995